2389 related articles for article (PubMed ID: 18472316)
41. Management of acute severe ulcerative colitis.
Doherty GA; Cheifetz AS
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):395-405. PubMed ID: 19673626
[TBL] [Abstract][Full Text] [Related]
42. Outcome following infliximab therapy in children with ulcerative colitis.
Hyams JS; Lerer T; Griffiths A; Pfefferkorn M; Stephens M; Evans J; Otley A; Carvalho R; Mack D; Bousvaros A; Rosh J; Grossman A; Tomer G; Kay M; Crandall W; Oliva-Hemker M; Keljo D; LeLeiko N; Markowitz J;
Am J Gastroenterol; 2010 Jun; 105(6):1430-6. PubMed ID: 20104217
[TBL] [Abstract][Full Text] [Related]
43. Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients.
Sjöberg M; Magnuson A; Björk J; Benoni C; Almer S; Friis-Liby I; Hertervig E; Olsson M; Karlén P; Eriksson A; Midhagen G; Carlson M; Lapidus A; Halfvarson J; Tysk C;
Aliment Pharmacol Ther; 2013 Aug; 38(4):377-87. PubMed ID: 23799948
[TBL] [Abstract][Full Text] [Related]
44. Intravenous cyclosporin in ulcerative colitis: a five-year experience.
Cohen RD; Stein R; Hanauer SB
Am J Gastroenterol; 1999 Jun; 94(6):1587-92. PubMed ID: 10364029
[TBL] [Abstract][Full Text] [Related]
45. Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis.
Moskovitz DN; Van Assche G; Maenhout B; Arts J; Ferrante M; Vermeire S; Rutgeerts P
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):760-5. PubMed ID: 16716758
[TBL] [Abstract][Full Text] [Related]
46. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ
Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
[TBL] [Abstract][Full Text] [Related]
47. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
[TBL] [Abstract][Full Text] [Related]
48. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
[TBL] [Abstract][Full Text] [Related]
49. Open-label infliximab therapy in ulcerative colitis: a multicenter survey of results and predictors of response.
Gonzalez-Lama Y; Fernandez-Blanco I; Lopez-SanRoman A; Taxonera C; Casis B; Tabernero S; Bermejo F; Martinez-Silva F; Mendoza JL; Martinez-Montiel P; Carneros JA; Sanchez F; Maté J; Gisbert JP;
Hepatogastroenterology; 2008; 55(86-87):1609-14. PubMed ID: 19102352
[TBL] [Abstract][Full Text] [Related]
50. Management of acute severe colitis.
Jakobovits SL; Travis SP
Br Med Bull; 2005; 75-76():131-44. PubMed ID: 16847166
[TBL] [Abstract][Full Text] [Related]
51. Infliximab for the treatment of acute exacerbations of ulcerative colitis.
Bryan S; Andronis L; Hyde C; Connock M; Fry-Smith A; Wang D
Health Technol Assess; 2010 May; 14 Suppl 1():9-15. PubMed ID: 20507798
[TBL] [Abstract][Full Text] [Related]
52. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
[TBL] [Abstract][Full Text] [Related]
53. Cyclosporine in severe ulcerative colitis refractory to steroid therapy.
Lichtiger S; Present DH; Kornbluth A; Gelernt I; Bauer J; Galler G; Michelassi F; Hanauer S
N Engl J Med; 1994 Jun; 330(26):1841-5. PubMed ID: 8196726
[TBL] [Abstract][Full Text] [Related]
54. Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis.
Rowe FA; Walker JH; Karp LC; Vasiliauskas EA; Plevy SE; Targan SR
Am J Gastroenterol; 2000 Aug; 95(8):2000-8. PubMed ID: 10950049
[TBL] [Abstract][Full Text] [Related]
55. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.
Protic M; Seibold F; Schoepfer A; Radojicic Z; Juillerat P; Bojic D; Mwinyi J; Mottet C; Jojic N; Beglinger C; Vavricka S; Rogler G; Frei P
J Crohns Colitis; 2014 Nov; 8(11):1427-37. PubMed ID: 24908178
[TBL] [Abstract][Full Text] [Related]
56. Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy.
Aloi M; D'Arcangelo G; Capponi M; Nuti F; Vassallo F; Civitelli F; Oliva S; Pagliaro G; Cucchiara S
Dig Liver Dis; 2015 Jun; 47(6):455-9. PubMed ID: 25733340
[TBL] [Abstract][Full Text] [Related]
57. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
Sandborn WJ; Rutgeerts P; Feagan BG; Reinisch W; Olson A; Johanns J; Lu J; Horgan K; Rachmilewitz D; Hanauer SB; Lichtenstein GR; de Villiers WJ; Present D; Sands BE; Colombel JF
Gastroenterology; 2009 Oct; 137(4):1250-60; quiz 1520. PubMed ID: 19596014
[TBL] [Abstract][Full Text] [Related]
58. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.
Mantzaris GJ; Archavlis E; Christoforidis P; Kourtessas D; Amberiadis P; Florakis N; Petraki K; Spiliadi C; Triantafyllou G
Am J Gastroenterol; 1997 Mar; 92(3):454-6. PubMed ID: 9068468
[TBL] [Abstract][Full Text] [Related]
59. Cyclosporin for severe ulcerative colitis attacks.
Danalioglu A; Kaymakoglu S; Mungan Z; Karaca C; Demir K; Durakoglu Z; Besisik F; Boztas G; Cakaloglu Y; Okyen A
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxcviii-ccc. PubMed ID: 15244207
[TBL] [Abstract][Full Text] [Related]
60. Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study.
Gustavsson A; Järnerot G; Hertervig E; Friis-Liby I; Blomquist L; Karlén P; Grännö C; Vilien M; Ström M; Verbaan H; Hellström PM; Magnuson A; Halfvarson J; Tysk C
Aliment Pharmacol Ther; 2010 Oct; 32(8):984-9. PubMed ID: 20937043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
